Literature DB >> 11136263

Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients.

C J Donskey1, T K Chowdhry, M T Hecker, C K Hoyen, J A Hanrahan, A M Hujer, R A Hutton-Thomas, C C Whalen, R A Bonomo, L B Rice.   

Abstract

BACKGROUND: Colonization and infection with vancomycin-resistant enterococci have been associated with exposure to antibiotics that are active against anaerobes. In mice that have intestinal colonization with vancomycin-resistant enterococci, these agents promote high-density colonization, whereas antibiotics with minimal antianaerobic activity do not.
METHODS: We conducted a seven-month prospective study of 51 patients who were colonized with vancomycin-resistant enterococci, as evidenced by the presence of the bacteria in stool. We examined the density of vancomycin-resistant enterococci in stool during and after therapy with antibiotic regimens and compared the effect on this density of antianaerobic agents and agents with minimal antianaerobic activity. In a subgroup of 10 patients, cultures of environmental specimens (e.g., from bedding and clothing) were obtained.
RESULTS: During treatment with 40 of 42 antianaerobic-antibiotic regimens (95 percent), high-density colonization with vancomycin-resistant enterococci was maintained (mean [+/-SD] number of organisms, 7.8+/-1.5 log per gram of stool). The density of colonization decreased after these regimens were discontinued. Among patients who had not received antianaerobic antibiotics for at least one week, 10 of 13 patients who began such regimens had an increase in the number of organisms of more than 1.0 log per gram (mean increase, 2.2 log per gram), whereas among 10 patients who began regimens of antibiotics with minimal antianaerobic activity, there was a mean decrease in the number of enterococci of 0.6 log per gram (P=0.006 for the difference between groups). When the density of vancomycin-resistant enterococci in stool was at least 4 log per gram, 10 of 12 sets of cultures of environmental specimens had at least one positive sample, as compared with 1 of 9 sets from patients with a mean number of organisms in stool of less than 4 log per gram (P=0.002).
CONCLUSIONS: For patients with vancomycin-resistant enterococci in stool, treatment with antianaerobic antibiotics promotes high-density colonization. Limiting the use of such agents in these patients may help decrease the spread of vancomycin-resistant enterococci.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11136263      PMCID: PMC4370337          DOI: 10.1056/NEJM200012283432604

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  35 in total

1.  Effect of vancomycin on intestinal flora of patients who previously received antimicrobial therapy.

Authors:  C Edlund; L Barkholt; B Olsson-Liljequist; C E Nord
Journal:  Clin Infect Dis       Date:  1997-09       Impact factor: 9.079

2.  Inactivation of quinolone by feces.

Authors:  J J van Saene; H K van Saene; C F Lerk
Journal:  J Infect Dis       Date:  1986-05       Impact factor: 5.226

3.  Effect of broad-spectrum cephalosporins on the microbial flora of recipients.

Authors:  G P Bodey; V Fainstein; I Garcia; B Rosenbaum; Y Wong
Journal:  J Infect Dis       Date:  1983-11       Impact factor: 5.226

4.  Resistant enterococci: a prospective study of prevalence, incidence, and factors associated with colonization in a university hospital.

Authors:  J W Weinstein; M Roe; M Towns; L Sanders; J J Thorpe; G R Corey; D J Sexton
Journal:  Infect Control Hosp Epidemiol       Date:  1996-01       Impact factor: 3.254

5.  Interindividual variability in biliary excretion of ceftriaxone: effects on biliary lipid metabolism and on intestinal microflora.

Authors:  A Arvidsson; B Leijd; C E Nord; B Angelin
Journal:  Eur J Clin Invest       Date:  1988-06       Impact factor: 4.686

6.  Selective decontamination of the digestive tract with aztreonam: a study of 10 healthy volunteers.

Authors:  H G de Vries-Hospers; G W Welling; E A Swabb; D van der Waaij
Journal:  J Infect Dis       Date:  1984-11       Impact factor: 5.226

7.  Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection.

Authors:  M B Edmond; J F Ober; D L Weinbaum; M A Pfaller; T Hwang; M D Sanford; R P Wenzel
Journal:  Clin Infect Dis       Date:  1995-05       Impact factor: 9.079

8.  A case-control study of nosocomial ampicillin-resistant enterococcal infection and colonization at a university hospital.

Authors:  D J Sexton; L J Harrell; J J Thorpe; D L Hunt; L B Reller
Journal:  Infect Control Hosp Epidemiol       Date:  1993-11       Impact factor: 3.254

9.  Enterococcal infections in patients treated with moxalactam.

Authors:  R C Moellering
Journal:  Rev Infect Dis       Date:  1982 Nov-Dec

10.  Enterococcal bacteremia in surgical patients.

Authors:  D T Barrall; P R Kenney; G J Slotman; K W Burchard
Journal:  Arch Surg       Date:  1985-01
View more
  205 in total

1.  Molecular characterization of vancomycin-resistant Enterococci repopulating the gastrointestinal tract following treatment with a novel glycolipodepsipeptide, ramoplanin.

Authors:  L R Baden; I A Critchley; D F Sahm; W So; M Gedde; S Porter; R C Moellering; G Eliopoulos
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

Review 2.  Effects of antibiotics on nosocomial epidemiology of vancomycin-resistant enterococci.

Authors:  Stephan Harbarth; Sara Cosgrove; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

Review 3.  All great truths are iconoclastic: selective decontamination of the digestive tract moves from heresy to level 1 truth.

Authors:  Hendrick K F van Saene; Andy J Petros; Graham Ramsay; Derrick Baxby
Journal:  Intensive Care Med       Date:  2003-04-10       Impact factor: 17.440

4.  Association between vancomycin-resistant Enterococci bacteremia and ceftriaxone usage.

Authors:  James A McKinnell; Danielle F Kunz; Eric Chamot; Mukesh Patel; Rhett M Shirley; Stephen A Moser; John W Baddley; Peter G Pappas; Loren G Miller
Journal:  Infect Control Hosp Epidemiol       Date:  2012-05-14       Impact factor: 3.254

5.  Acquisition and duration of vancomycin-resistant enterococcal carriage in relation to strain type.

Authors:  E M Mascini; K P Jalink; T E M Kamp-Hopmans; H E M Blok; J Verhoef; M J M Bonten; A Troelstra
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

6.  Selective decontamination of the digestive tract: to stimulate or stifle?

Authors:  Marc J M Bonten; Christian Brun-Buisson; Robert A Weinstein
Journal:  Intensive Care Med       Date:  2003-05       Impact factor: 17.440

7.  Aliens, anaerobes, and the lung!

Authors:  Paul Marik
Journal:  Intensive Care Med       Date:  2003-07       Impact factor: 17.440

8.  Comparison of PCR assay to culture for surveillance detection of vancomycin-resistant enterococci.

Authors:  Suzanne M Paule; William E Trick; Fred C Tenover; Mary Lankford; Susan Cunningham; Valentina Stosor; Ralph L Cordell; Lance R Peterson
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

Review 9.  Rapid detection of antimicrobial-resistant organism carriage: an unmet clinical need.

Authors:  Daniel J Diekema; Kirsty J Dodgson; Bryndis Sigurdardottir; Michael A Pfaller
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

Review 10.  Mechanisms of resistance and clinical relevance of resistance to β-lactams, glycopeptides, and fluoroquinolones.

Authors:  Louis B Rice
Journal:  Mayo Clin Proc       Date:  2012-02       Impact factor: 7.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.